News
Today's highlights include: Study mines cancer genetics to help with targeted treatment, Mayo Clinic to launch staffing tool app to find 'right nurse for the right role', and new blood biomarker may lead to early diagnosis of frontotemporal dementia.
Mayo Clinic recently announced plans to invest in an expansion project to enhance laboratory medicine. The expansion project will support Mayo Clinic Laboratories' goal to provide diagnostics to Mayo Clinic patients throughout the nation and abroad. Health care teams around the world will have access to laboratory testing through Mayo Clinic Laboratories' Test Catalog, and Mayo Clinic patients will have access to testing via their Mayo Clinic health care providers.
Topics include: Why women's risk of heart disease increased during the pandemic and information about the most commonly asked questions for when to get your second COVID-19 booster.
Today's highlights include: Facing 'alarming' health care worker shortage, unusual cases of hepatitis in young children, and why women's risk of heart disease increased during the pandemic.
Topic's Include: Testing wastewater for COVID-19: The clearest path to understanding community infection, and the latest advice about COVID-19 boosters.
Mayo Clinic researchers have identified clear differences in brain and spinal cord scarring in patients with demyelinating diseases.
Today's Highlights Include: 5 reasons to consider becoming an organ donor, why so many women in middle age are on antidepressants, and should you get a second COVID-19 vaccine booster?
In March 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Saliva testing has emerged as a viable option for obtaining rapid, reliable test results during the COVID-19 pandemic. Mayo Clinic’s Dr. Darci Block considers how this type of testing may expand beyond the pandemic, and the obstacles in its way.
Topic's Include: Transplant, new model of care give hope to Salvadoran mom after cancer diagnosis, what you need to know about the COVID-19 BA.2 subvariant, and why calling the highly contagious COVID-19 omicron BA.2 a ‘stealth variant’ is a misnomer.
Today's Highlights Include: Walz signs ALS bill by senator with the disease, Health Fusion: A farm family's journey from tragedy to gratefulness through organ donation, and google Search will soon let you book checkups and other medical appointments.
Today's Highlights Include: e-changing kidney swap, climate change is making allergy season even worse, and a Minnesota Milestone: A day without COVID-19 deaths.
Mayo Clinic researchers have developed and validated a new antibody test to diagnose multiple sclerosis (MS). The new test is an automated and cost-effective method compared to other tests used to diagnose MS, according to the research published in Mayo Clinic Proceedings. The test is now available through Mayo Clinic Laboratories.